Cytokinetics, Incorporated earnings per share and revenue

CYTK earnings per share for the last quarter are -1.33 USD whereas the estimation was -1.15 USD which accounts for -15.66% surprise. Företagets omsättning för samma period uppgår till 835.00 k USD trots den uppskattade siffran 912.85 k USD. Estimated earnings per share for the next quarter are -1.17 USD, and revenue is expected to reach 948.44 k USD. Also watch annual changes over time to get a bigger picture of CYTK earnings per share and revenue dynamics.